CICC Research Begins Coverage on Astera Labs (NASDAQ:ALAB)

Key Points

• CICC Research has initiated coverage on Astera Labs (NASDAQ:ALAB) with an "outperform" rating and a price target of $190.00, indicating a potential upside of 0.45% from its previous close.
• A diverse group of analysts have varied ratings on Astera Labs, with the majority being positive; the consensus rating is a "Moderate Buy" with a target price of $132.94.
• The company reported strong financial results for the last quarter, exceeding earnings expectations with $191.93 million in revenue, which is a 149.5% increase compared to the previous year.

CICC Research assumed coverage on shares of Astera Labs (NASDAQ:ALAB - Free Report) in a report released on Friday morning, MarketBeat.com reports. The firm issued an outperform rating and a $190.00 target price on the stock.

ALAB has been the subject of a number of other reports. Barclays reiterated an "overweight" rating and issued a $155.00 price objective (up from $75.00) on shares of Astera Labs in a research report on Thursday, August 7th. Wall Street Zen upgraded Astera Labs from a "hold" rating to a "buy" rating in a report on Saturday, August 16th. Stifel Nicolaus set a $145.00 target price on Astera Labs and gave the stock a "buy" rating in a report on Monday, August 4th. Susquehanna raised their target price on Astera Labs from $80.00 to $125.00 and gave the stock a "neutral" rating in a report on Thursday, August 7th. Finally, Zacks Research upgraded Astera Labs to a "strong-buy" rating in a report on Tuesday, August 12th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average price target of $142.00.

Astera Labs Price Performance

Shares of NASDAQ:ALAB traded down $11.83 during midday trading on Friday, reaching $170.37. The company's stock had a trading volume of 3,631,552 shares, compared to its average volume of 4,921,390. Astera Labs has a fifty-two week low of $36.85 and a fifty-two week high of $199.47. The company has a market capitalization of $28.32 billion, a P/E ratio of 304.59, a P/E/G ratio of 4.62 and a beta of 1.46. The business's fifty day simple moving average is $134.36 and its 200-day simple moving average is $96.42.

Astera Labs (NASDAQ:ALAB - Get Free Report) last announced its earnings results on Tuesday, August 5th. The company reported $0.44 earnings per share for the quarter, beating analysts' consensus estimates of $0.33 by $0.11. Astera Labs had a return on equity of 9.53% and a net margin of 16.54%.The company had revenue of $191.93 million during the quarter, compared to analyst estimates of $172.46 million. During the same period last year, the company posted $0.13 earnings per share. The firm's quarterly revenue was up 149.5% compared to the same quarter last year. Astera Labs has set its Q3 2025 guidance at 0.380-0.390 EPS. On average, analysts forecast that Astera Labs will post 0.34 earnings per share for the current fiscal year.

Insider Transactions at Astera Labs

In other Astera Labs news, CFO Michael Truett Tate sold 18,861 shares of the business's stock in a transaction that occurred on Monday, August 18th. The stock was sold at an average price of $183.51, for a total value of $3,461,182.11. Following the sale, the chief financial officer owned 259,512 shares in the company, valued at approximately $47,623,047.12. The trade was a 6.78% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CEO Jitendra Mohan sold 91,441 shares of the business's stock in a transaction that occurred on Monday, August 18th. The shares were sold at an average price of $183.51, for a total value of $16,780,337.91. Following the completion of the sale, the chief executive officer owned 2,170,877 shares in the company, valued at $398,377,638.27. The trade was a 4.04% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 1,728,116 shares of company stock worth $239,272,181. Corporate insiders own 12.50% of the company's stock.

Institutional Investors Weigh In On Astera Labs

Several institutional investors have recently bought and sold shares of ALAB. Alliancebernstein L.P. increased its position in shares of Astera Labs by 114.2% during the 1st quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company's stock worth $501,289,000 after purchasing an additional 4,478,741 shares during the last quarter. Atreides Management LP increased its position in shares of Astera Labs by 153.3% during the 1st quarter. Atreides Management LP now owns 4,652,264 shares of the company's stock worth $277,601,000 after purchasing an additional 2,815,614 shares during the last quarter. Vanguard Group Inc. increased its position in shares of Astera Labs by 29.6% during the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company's stock worth $1,089,491,000 after purchasing an additional 2,751,747 shares during the last quarter. Driehaus Capital Management LLC increased its position in shares of Astera Labs by 16,640.4% during the 4th quarter. Driehaus Capital Management LLC now owns 1,324,330 shares of the company's stock worth $175,408,000 after purchasing an additional 1,316,419 shares during the last quarter. Finally, FengHe Fund Management Pte. Ltd. acquired a new position in shares of Astera Labs during the 2nd quarter worth approximately $106,772,000. Institutional investors own 60.47% of the company's stock.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.